Research Article
The lncRNA B3GALT5-AS1 Functions as an HCC Suppressor by Regulating the miR-934/UFM1 Axis
Table 2
Correlation of B3GALT5-AS1 expression with clinicopathologic characteristics in HCC patients.
| Characteristic | Case | B3GALT5-AS1 expression | value | Low | High |
| All case | 56 | 28 | 28 | | Age (years) | | | | 0.584 | <60 | 22 | 10 | 12 | | ≥60 | 34 | 18 | 16 | | Gender | | | | 0.788 | Female | 25 | 12 | 13 | | Male | 31 | 16 | 15 | | Tumor size (cm) | | | | 0.022 | <5 cm | 38 | 23 | 15 | | ≥5 cm | 18 | 5 | 13 | | Liver cirrhosis | | | | 0.313 | No | 11 | 4 | 7 | | Yes | 45 | 24 | 21 | | HBsAg status | | | | 0.515 | Negative | 12 | 5 | 7 | | Positive | 44 | 23 | 21 | | AFP (ng/ml) | | | | 0.108 | ≤20 | 26 | 16 | 10 | | >20 | 30 | 12 | 18 | | Tumor multiplicity | | | | 0.383 | Single | 39 | 21 | 18 | | Multiple | 17 | 7 | 10 | | Edmondson grade | | | | 0.42 | I–II | 31 | 17 | 14 | | III–IV | 25 | 11 | 14 | | TNM stage | | | | 0.003 | I–II | 33 | 22 | 11 | | III–IV | 23 | 6 | 17 | |
|
|